Multifunctional polymeric nanocapsules with enhanced cartilage penetration and retention for osteoarthritis treatment

Hongxiang Mei,Chuanlu Sha,Qinyi Lv,Hai Liu,Linli Jiang,Qiantao Song,Yiwei Zeng,Jiawei Zhou,Yule Zheng,Wenbin Zhong,Jiajing Zhou,Juan Li

DOI: https://doi.org/10.1016/j.jconrel.2024.08.031

2024-08-26

Abstract:Osteoarthritis (OA) is a prevalent joint disease characterized by cartilage degeneration and subchondral bone homeostasis imbalance. Effective topical OA therapy is challenging, as therapeutic drugs often suffer from insufficient penetration and rapid clearance. We develop miniature polydopamine (PDA) nanocapsules (sub-60 nm), which are conjugated with collagen-binding polypeptide (CBP) and loaded with an anabolic drug (i.e., parathyroid hormone 1-34, PTH 1-34) for efficient OA treatment. Such multifunctional polymeric nanocapsules, denoted as PDA@CBP-PTH, possess deformability when interacting with the dense collagen fiber networks, enabling the efficient penetration into 1 mm cartilage in 4 h and prolonged retention within the joints up to 28 days. Moreover, PDA@CBP-PTH nanocapsules exhibit excellent reactive oxygen species scavenging property in chondrocytes and enhance the anabolism in subchondral bone. The nanosystem, as dual-mode treatment for OA, demonstrates rapid penetration, long-lasting effects, and combinational therapeutic impact, paving the way for reversing the progression of OA for joint health care.